IRCT20090808002306N10
Recruiting
Phase 3
Clinical trial of the effectiveness of melatonin as an add-on treatment to the common treatment of melasma
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Melasma.
- Sponsor
- Esfahan University of Medical Sciences
- Enrollment
- 44
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Obtaining the intensity and melasma area index score (massi score) 10
- •Not using other topical treatments at least two weeks before participating in the research project
- •No use of systemic steroids for the treatment of melasma for at least one month before participating in the research project
- •Not using other treatment methods such as laser to treat melasma for at least 3 months before participating in the research project
- •Consent and informed consent of the person to enter this research project
Exclusion Criteria
- •Patients non\-compliance to the study protocol
- •Utilization of other anti melasma treatments
- •Patients' personal will to the exclusion from the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Effect of melatonin supplementation in treatment of maintenance methadone treatment patientsAddiction.Mental and behavioural disorders due to multiple drug use and use of other psychoactive substancesIRCT2017072933551N3Vice chancellor for research, Kashan University of Medical Sciences60
Recruiting
Phase 4
Evaluation of effect of melatonin on the duration of mechanical ventilation in patients requiring hospitalization in the intensive care unitDependence on respirator.Dependence on respiratorIRCT20170729035360N1Deputy of Research and Technology Development of the ?Ahvaz Jundishapur University of Medical Scienc60
Completed
Phase 2
Effect of melatonin supplementation in treatment of patients with Parkinson's diseaseIRCT20170513033941N29Kashan University of Medical Sciences60
Completed
Phase 3
Effect of melatonin supplementation in treatment of diabetic hemodialysis patientsHemodialysis.Chronic kidney disease (CKD)IRCT20170513033941N31Kashan University of Medical Sciences60
Completed
Not Applicable
Effect of melatonin supplementation in treatment of women with polycystic ovary syndromeIRCT2017082733941N9Vice chancellor for research, Arak University of Medical Sciences60